Dan Lou

1.1k total citations
48 papers, 829 citations indexed

About

Dan Lou is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Dan Lou has authored 48 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 8 papers in Surgery and 7 papers in Cancer Research. Recurrent topics in Dan Lou's work include Paraquat toxicity studies and treatments (7 papers), Epigenetics and DNA Methylation (5 papers) and RNA Interference and Gene Delivery (4 papers). Dan Lou is often cited by papers focused on Paraquat toxicity studies and treatments (7 papers), Epigenetics and DNA Methylation (5 papers) and RNA Interference and Gene Delivery (4 papers). Dan Lou collaborates with scholars based in China, United States and Hong Kong. Dan Lou's co-authors include Zhijun Zhou, Zhibin Wang, Ming Xu, Jianhua Zhang, Xiuli Chang, Huishan Wang, Yusaku Nakabeppu, Lu Zhang, Dongsheng Zhang and Dongtao Zhang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Journal of Neurochemistry.

In The Last Decade

Dan Lou

47 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Lou China 17 411 122 83 78 71 48 829
Hyun‐Jin Tae South Korea 21 494 1.2× 141 1.2× 88 1.1× 70 0.9× 89 1.3× 99 1.4k
Sara Salucci Italy 22 506 1.2× 139 1.1× 59 0.7× 36 0.5× 73 1.0× 59 1.1k
Andrea Gerbino Italy 21 592 1.4× 69 0.6× 90 1.1× 57 0.7× 56 0.8× 54 1.1k
Soyoung Lee South Korea 16 500 1.2× 201 1.6× 66 0.8× 75 1.0× 174 2.5× 23 1.3k
Cheng Peng China 17 459 1.1× 100 0.8× 43 0.5× 86 1.1× 102 1.4× 40 976
Salil Srivastava United Kingdom 12 420 1.0× 113 0.9× 60 0.7× 33 0.4× 36 0.5× 19 981
Nihar R. Pandey Canada 17 451 1.1× 95 0.8× 81 1.0× 40 0.5× 93 1.3× 22 976
Shujie Shi United States 12 684 1.7× 58 0.5× 52 0.6× 53 0.7× 48 0.7× 28 1.2k
Songyan Liu China 22 431 1.0× 59 0.5× 59 0.7× 60 0.8× 72 1.0× 67 1.2k
Pramod Sukumaran United States 20 626 1.5× 203 1.7× 76 0.9× 45 0.6× 155 2.2× 40 1.3k

Countries citing papers authored by Dan Lou

Since Specialization
Citations

This map shows the geographic impact of Dan Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Lou more than expected).

Fields of papers citing papers by Dan Lou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Lou. The network helps show where Dan Lou may publish in the future.

Co-authorship network of co-authors of Dan Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Lou. A scholar is included among the top collaborators of Dan Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Lou. Dan Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lou, Dan, et al.. (2023). MiR-5189-3p Suppresses cell Proliferation, Invasion and Migration Through Targeting EIF5A2 in Laryngeal Squamous Cell Carcinoma. Biochemical Genetics. 62(3). 1603–1616. 1 indexed citations
2.
Zhang, Hui, et al.. (2022). Therapeutic effect and metabolomics mechanism of Patrinia Villosa (Thunb.) juss on liver injury in rats. Frontiers in Pharmacology. 13. 1058587–1058587. 1 indexed citations
3.
Lou, Dan, Adhithiya Charli, Dehui Kong, et al.. (2021). Mitochondrial dysfunction–induced H3K27 hyperacetylation perturbs enhancers in Parkinson’s disease. JCI Insight. 6(17). 27 indexed citations
4.
Ding, Yu, Niu Li, Dan Lou, et al.. (2020). Clinical and genetic analysis in a Chinese cohort of children and adolescents with diabetes/persistent hyperglycemia. Journal of Diabetes Investigation. 12(1). 48–62. 7 indexed citations
5.
Lou, Dan, et al.. (2020). Demethylation of the NRF2 Promoter Protects Against Carcinogenesis Induced by Nano-SiO2. Frontiers in Genetics. 11. 818–818. 6 indexed citations
6.
Wang, Weizhong, Zhijuan Wang, Meili Zhu, et al.. (2020). A mobile terminal application program was used for endotracheal tube cuff pressure measurement. Journal of Clinical Monitoring and Computing. 35(3). 463–468. 8 indexed citations
7.
Wang, Huishan, Dan Lou, & Zhibin Wang. (2019). Crosstalk of Genetic Variants, Allele-Specific DNA Methylation, and Environmental Factors for Complex Disease Risk. Frontiers in Genetics. 9. 695–695. 55 indexed citations
8.
Lou, Dan, et al.. (2019). Inhibitory Mechanisms of Myricetin on Human and Rat Liver Cytochrome P450 Enzymes. European Journal of Drug Metabolism and Pharmacokinetics. 44(5). 611–618. 19 indexed citations
9.
Wu, Siyu, Lili Lei, Yang Song, et al.. (2018). Mutation of hop-1 and pink-1 attenuates vulnerability of neurotoxicity in C. elegans: the role of mitochondria-associated membrane proteins in Parkinsonism. Experimental Neurology. 309. 67–78. 39 indexed citations
10.
Teng, Li, Ramon Bossardi Ramos, Dan Lou, et al.. (2017). Two approaches reveal a new paradigm of ‘switchable or genetics-influenced allele-specific DNA methylation’ with potential in human disease. Cell Discovery. 3(1). 17038–17038. 14 indexed citations
11.
Lou, Dan, et al.. (2016). Characterization of Microcystin-Induced Dualistic Toxic Effects on Primary Rat Hepatocytes. Journal of Environmental Pathology Toxicology and Oncology. 36(1). 15–27. 10 indexed citations
12.
Huang, Min, et al.. (2016). Paraquat inhibited differentiation in human neural progenitor cells (hNPCs) and down regulated miR-200a expression by targeting CTNNB1. Environmental Toxicology and Pharmacology. 42. 205–211. 8 indexed citations
13.
Zhang, Wanli, et al.. (2016). Determination of rivaroxaban, apixaban and edoxaban in rat plasma by UPLC–MS/MS method. Journal of Thrombosis and Thrombolysis. 42(2). 205–211. 50 indexed citations
14.
Qiu, Xiangjun, et al.. (2015). Simultaneous determination of acetaminophen and dihydrocodeine in human plasma by UPLC–MS/MS: Its pharmacokinetic application. Journal of Chromatography B. 992. 91–95. 17 indexed citations
15.
Yan, Mengling, Lina Zhao, Dan Lou, et al.. (2015). Nrf2/ARE Pathway Involved in Oxidative Stress Induced by Paraquat in Human Neural Progenitor Cells. Oxidative Medicine and Cellular Longevity. 2016(1). 8923860–8923860. 52 indexed citations
16.
Sun, Yan, et al.. (2010). The influence of SYT-SSX fusion gene, E-cadherin and β-catenin on the metastasis of synovial sarcoma. Clinical Oncology and Cancer Research. 37(4). 205–208. 2 indexed citations
17.
Lou, Dan, et al.. (2010). Pilot study on the relationship of LPPCN with neovascularization and prognosis of melanoma. Clinical Oncology and Cancer Research. 37(2). 80–84.
18.
Yang, Jie, Shiying Guo, Feiyan Pan, et al.. (2006). Prokaryotic expression and polyclonal antibody preparation of a novel Rab-like protein mRabL5. Protein Expression and Purification. 53(1). 1–8. 21 indexed citations
19.
Zhang, Jianhua, et al.. (2001). DNA Fragmentation Factor 45 Mutant Mice Exhibit Resistance to Kainic Acid-Induced Neuronal Cell Death. Biochemical and Biophysical Research Communications. 285(5). 1143–1149. 16 indexed citations
20.
Zhang, Jianhua, et al.. (2000). Lack of Obvious 50 Kilobase Pair DNA Fragments in DNA Fragmentation Factor 45-Deficient Thymocytes upon Activation of Apoptosis. Biochemical and Biophysical Research Communications. 274(1). 225–229. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026